Clinical Trials Directory

Trials / Completed

CompletedNCT02271672

XP1000 RF Therapy on Waist Circumference Reduction

Effect of the XP1000 RF Therapy on Waist Circumference Reduction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
BTL Industries Ltd. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study was designed to demonstrate safety and efficacy of the XP1000 RF for non-invasive temporary reduction of waist circumference by disruption of adipocyte cells.

Detailed description

This study is a prospective, double-blinded, randomized, two-arm sham-controlled study of circumferential waist reduction following 4 treatment sessions delivered once a week over a 4-week period. The objective of the study is to demonstrate the effectiveness of the treatment after 30-day and 90-day Follow Up in achieving waist circumference reduction of ≥3 cm across the waist line relative to the base line assessment and their mean waist circumferential reduction is ≥1 cm than the average circumferential reduction of sham group.

Conditions

Interventions

TypeNameDescription
DEVICEXP1000 RFTreatment of adipose tissue within the fat layer with XP1000 RF.
DEVICEsham XP1000 RFTreatment of adipose tissue within the fat layer with XP1000 RF.

Timeline

Start date
2014-08-01
Primary completion
2015-03-01
Completion
2015-06-01
First posted
2014-10-22
Last updated
2015-06-18

Source: ClinicalTrials.gov record NCT02271672. Inclusion in this directory is not an endorsement.